{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:33:10Z","timestamp":1790731990903,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Defective synthesis of the \u03b1-globin chain due to mutations in the alpha-globin genes and\/or its regulatory elements leads to alpha thalassaemia syndrome. Complete deletion of the 4 alpha-globin genes results in the most severe phenotype known as haemoglobin Bart\u2019s, which leads to intrauterine death. The presence of one functional alpha gene is associated with haemoglobin H disease, characterised by non-transfusion-dependent thalassaemia phenotype, while silent and carrier traits are mostly asymptomatic.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Main body<\/jats:title>\n<jats:p>Clinical manifestations of non-deletional in alpha thalassaemia are varied and have more severe phenotype compared to deletional forms of alpha thalassaemia. Literature for the molecular mechanisms of common non-deletional alpha thalassaemia including therapeutic measures that are necessarily needed for the understanding of these disorders is still in demand. This manuscript would contribute to the better knowledge of how defective production of the \u03b1-globin chains due to mutations on the alpha-globin genes and\/or the regulatory elements leads to alpha thalassaemia syndrome.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Since many molecular markers are associated with the globin gene expression and switching over during the developmental stages, there is a need for increased awareness, new-born and prenatal screening program, especially for countries with high migration impact, and for improving the monitoring of patients with \u03b1-thalassaemia.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-020-01429-1","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T11:02:59Z","timestamp":1593428579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Non-deletional alpha thalassaemia: a review"],"prefix":"10.1186","volume":"15","author":[{"given":"Ibrahim","family":"Kalle Kwaifa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei I.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2292-5149","authenticated-orcid":false,"given":"Sabariah","family":"Md Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"issue":"9813","key":"1429_CR1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(11)60283-3","volume":"379","author":"DR Higgs","year":"2012","unstructured":"Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379(9813):373\u201383.","journal-title":"Lancet"},{"issue":"10116","key":"1429_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","volume":"391","author":"AT Taher","year":"2018","unstructured":"Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155\u201367.","journal-title":"Lancet"},{"issue":"2","key":"1429_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.hoc.2017.11.003","volume":"32","author":"S Mettananda","year":"2018","unstructured":"Mettananda S, Higgs DR. Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am. 2018;32(2):177\u201391. Available from. https:\/\/doi.org\/10.1016\/j.hoc.2017.11.003.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"24","key":"1429_CR4","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1182\/blood-2015-03-633594","volume":"125","author":"S Mettananda","year":"2015","unstructured":"Mettananda S, Gibbons RJ, Higgs DR. \u0391-globin as a molecular target in the treatment of \u0392-thalassemia. Blood. 2015;125(24):3694\u2013701.","journal-title":"Blood."},{"issue":"2","key":"1429_CR5","first-page":"103","volume":"24","author":"SW John","year":"2001","unstructured":"John SW, David HK, Chui MD. The \u03b1-globin gene: genetics and disorders. Clin Invest Med. 2001;24(2):103 ProQuest Central pg.","journal-title":"Clin Invest Med"},{"key":"1429_CR6","first-page":"1521","volume-title":"Campbell Biology","author":"BR Jane","year":"2015","unstructured":"Jane BR, Noel M, Lisa AU, Michael LC, Steven AW, Peter VM. Campbell Biology. Australian and New Zealand: Pearson Higher Education.AU. Copyright; 2015. p. 1521."},{"key":"1429_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcmd.2017.02.002","volume":"70","author":"D Vernimmen","year":"2018","unstructured":"Vernimmen D. Globins, from genes to physiology and diseases. Blood Cells Mol Dis. 2018;70:1. Available from. https:\/\/doi.org\/10.1016\/j.bcmd.2017.02.002.","journal-title":"Blood Cells Mol Dis"},{"issue":"15","key":"1429_CR8","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood-2012-06-292078","volume":"120","author":"DE Bauer","year":"2012","unstructured":"Bauer DE, Kamran SC, Orkin SH. Reawakening fetal haemoglobin: prospects for new therapies for beta-globin disorders. Blood. 2012;120(15):2945\u201353.","journal-title":"Blood."},{"issue":"9","key":"1429_CR9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ng.637","volume":"42","author":"D Zhou","year":"2010","unstructured":"Zhou D, Liu K, Sun CW, et al. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat Genet. 2010;42(9):742\u20134.","journal-title":"Nat Genet"},{"issue":"6270","key":"1429_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.aad3312","volume":"351","author":"T Masuda","year":"2016","unstructured":"Masuda T, Wang X, Maeda M, et al. Transcription factors LRF and BCL11A independently repress expression of fetal haemoglobin. Science. 2016;351(6270):285\u20139.","journal-title":"Science."},{"issue":"R2","key":"1429_CR11","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1093\/hmg\/ddw170","volume":"25","author":"EC Smith","year":"2016","unstructured":"Smith EC, Orkin SH. Haemoglobin genetics: recent contributions of GWAS and gene editing. Hum Mol Genet. 2016;25(R2):R99\u2013105.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1429_CR12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOH.0b013e3282f734c4","volume":"15","author":"DR Higgs","year":"2008","unstructured":"Higgs DR, Wood WG. Long-range regulation of alpha-globin gene expression during erythropoiesis. Curr Opin Hematol. 2008;15(3):176\u201383.","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"1429_CR13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/bjh.14005","volume":"176","author":"MY Wu","year":"2017","unstructured":"Wu MY, He Y, Yan JM, et al. Novel selective deletion of the major alpha-globin regulatory element (MCS-R2) causing alpha-thalassaemia. Br J Haematol. 2017;176(6):984\u20136.","journal-title":"Br J Haematol"},{"key":"1429_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5772\/31362","volume-title":"Molecular Basis of Thalassemia, Anemia, InTechOpen","author":"M Grosso","year":"2012","unstructured":"Grosso M, Sessa R, Puzone S, Maria Rosaria Storino PI. Molecular Basis of Thalassemia, Anemia, InTechOpen; 2012. p. 346\u20139. https:\/\/doi.org\/10.5772\/31362."},{"key":"1429_CR15","doi-asserted-by":"publisher","unstructured":"Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, Fourth Edition. 2001. ISBN:9780865426641 |Online ISBN:9780470696705| https:\/\/doi.org\/10.1002\/9780470696705. Copyright \u00a9 2001 Blackwell Science Ltd.","DOI":"10.1002\/9780470696705"},{"key":"1429_CR16","doi-asserted-by":"publisher","unstructured":"Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program. 2009;2009(1):26\u201334. https:\/\/doi.org\/10.1182\/asheducation-2009.1.26.","DOI":"10.1182\/asheducation-2009.1.26"},{"issue":"4","key":"1429_CR17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4274\/tjh.2014.0204","volume":"32","author":"Z Karaka\u015f","year":"2015","unstructured":"Karaka\u015f Z, Ko\u00e7 B, Temurhan S, Elg\u00fcn T, Karaman S, Asker G, et al. Hipokromik Mikrositer Anemili Olgularda Alfa Talasemi Mutasyonlar\u0131n\u0131n De\u011ferlendirmesi: \u0130stanbul Perspektifi. Turkish J Hematol. 2015;32(4):344\u201350.","journal-title":"Turkish J Hematol"},{"issue":"September","key":"1429_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bcmd.2017.09.004","volume":"70","author":"S Farashi","year":"2018","unstructured":"Farashi S, Harteveld CL. Molecular basis of \u03b1-thalassemia. Blood Cells Mol Dis. 2018;70(September):43\u201353. Available from:. https:\/\/doi.org\/10.1016\/j.bcmd.2017.09.004.","journal-title":"Blood Cells Mol Dis"},{"key":"1429_CR19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/03630260802173833","volume":"32","author":"HJ Wajcman","year":"2008","unstructured":"Wajcman HJ, Traeger-Synodinos I, Papassotiriou PC, Giordano CL, Harteveld V, Baudin-Creuza JO. Unstable and thalassemic alpha chain haemoglobin variants: a cause of Hb H disease and thalassemia intermedia. Hemoglobin. 2008;32:327\u201349.","journal-title":"Hemoglobin"},{"key":"1429_CR20","volume-title":"Prevention of Thalassaemias and Other Haemoglobin Disorders","author":"J Old","year":"2016","unstructured":"Old J, Angastiniotis M, Eleftheriou A, Galanello R, Harteveld CL, Petrou M, Traeger-Synodinos J. Prevention of Thalassaemias and Other Haemoglobin Disorders, vol. 1. Nicosia, (Ref Type: Generic): Thalassaemia International Federation; 2016."},{"key":"1429_CR21","doi-asserted-by":"crossref","first-page":"D1063","DOI":"10.1093\/nar\/gkt911","volume":"42","author":"B Giardine","year":"2014","unstructured":"Giardine B, Borg J, Viennas E, Pavlidis C, Moradkhani K, Joly P, et al. Updates of the HbVar database of human haemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42:D1063\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1429_CR22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.785","volume":"43","author":"B Giardine","year":"2011","unstructured":"Giardine B, Borg J, Higgs DR, Peterson KR, Philipsen S, Maglott D, et al. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the micro attribution approach. Nat Genet. 2011;43:295\u2013301.","journal-title":"Nat Genet"},{"key":"1429_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-5-13","volume":"5","author":"LH Cornelis","year":"2010","unstructured":"Cornelis LH, Douglas RH. \u03b1-thalassaemia: Review. Orphanet J Rare Dis. 2010;5:13.","journal-title":"Orphanet J Rare Dis"},{"issue":"MARCH","key":"1429_CR24","first-page":"315","volume":"143","author":"S Pharephan","year":"2016","unstructured":"Pharephan S, Sirivatanapa P, Makonkawkeyoon S, Tuntiwechapikul W, Makonkawkeyoon L. Prevalence of \u03b1-thalassaemia genotypes in pregnant women in northern Thailand. Indian J Med Res. 2016;143(MARCH):315\u201322.","journal-title":"Indian J Med Res"},{"issue":"3","key":"1429_CR25","first-page":"21","volume":"6","author":"YC Wee","year":"2009","unstructured":"Wee YC, Tan KL, Chua KH, George E, Jama T. Molecular characterisation of Haemoglobin Constant Spring and Haemoglobin Quong Sze with a combine-amplification refractory mutation system. Malays J Med Sci. 2009;6(3):21\u20138.","journal-title":"Malays J Med Sci"},{"issue":"March","key":"1429_CR26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1100\/tsw.2009.69","volume":"9","author":"ST Singer","year":"2009","unstructured":"Singer ST. Variable clinical phenotypes of \u03b1-thalassemia syndromes. ScientificWorldJournal. 2009;9(March):615\u201325.","journal-title":"ScientificWorldJournal."},{"key":"1429_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/03630269.2011.637149","volume":"36","author":"J Tritipsombut","year":"2012","unstructured":"Tritipsombut J, Sanchaisuriya K, Phollarp P, Bouakhasith D, Sanchaisuriya P, Fucharoen G, et al. Micromapping of thalassemia and hemoglobinopathies in different regions of Northeast Thailand and Vientiane, Laos People\u2019s Democratic Republic. Haemoglobin. 2012;36:47\u201356.","journal-title":"Haemoglobin"},{"key":"1429_CR28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00277-007-0310-x","volume":"86","author":"S Singsanan","year":"2007","unstructured":"Singsanan S, Fucharoen G, Savongsy O, Sanchaisuriya K, Fucharoen S. Molecular characterization and origins of Hb constant spring and Hb Pakse' in southeast Asian populations. Ann Hematol. 2007;86:665\u20139.","journal-title":"Ann Hematol"},{"issue":"9","key":"1429_CR29","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1182\/blood-2003-11-3957","volume":"103","author":"V Viprakasit","year":"2004","unstructured":"Viprakasit V, Tanphaichitr VS, Chinchang W, Sangkla P, Weiss MJ, Higgs DR. Evaluation of alpha haemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with \u03b2 thalassemia. Blood. 2004;103(9):3296\u20139.","journal-title":"Blood."},{"key":"1429_CR30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.mph.0000243662.56432.37","volume":"28","author":"P Charoenkwan","year":"2006","unstructured":"Charoenkwan P, Sirichotiyakul S, Chanprapaph P, Tongprasert F, Taweephol R, Sae-Tung R, Sanguansermsri T. Anemia and hydrops in a fetus with homozygous haemoglobin constant spring. J Pediatr Hematol Oncol. 2006;28:827\u201330.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1429_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/03630260601059332","volume":"31","author":"D Li","year":"2007","unstructured":"Li D, Liao C, Li J. Misdiagnosis of Hb constant spring (alpha142, term-->Gln, TAA-->CAA in alpha2) in a Hb H (beta4) disease child. Haemoglobin. 2007;31:105\u20138.","journal-title":"Haemoglobin."},{"issue":"SUPPL.1","key":"1429_CR32","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/S0268-960X(12)70010-3","volume":"26","author":"E Vichinsky","year":"2012","unstructured":"Vichinsky E. Advances in the treatment of alpha-thalassemia. Blood Rev. 2012;26(SUPPL.1):S31\u20134. Available from:. https:\/\/doi.org\/10.1016\/S0268-960X(12)70010-3.","journal-title":"Blood Rev"},{"issue":"3","key":"1429_CR33","first-page":"23","volume":"16","author":"YC Wee","year":"2009","unstructured":"Wee YC, Tan KL, Chua KH, George E, Tan JAMA. Molecular characterisation of Haemoglobin constant spring and Haemoglobin Quong Sze with a combine-amplification refractory mutation system. Malays J Med Sci. 2009b;16(3):23\u201330.","journal-title":"Malays J Med Sci"},{"issue":"3","key":"1429_CR34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/03630269.2014.910669","volume":"38","author":"YJ Yong","year":"2014","unstructured":"Yong YJ, Lui YH, Dong-Zhi L. Screening and Diagnosis of Hb Quong Sze [HBA2: c.377T\u2009>\u2009C (or HBA1)] in a Prenatal Control Program for Thalassaemia. Hemoglobin. 2014;38(3):158\u201360.","journal-title":"Hemoglobin"},{"key":"1429_CR35","unstructured":"Brigitte G, Jacques S, Catherine B, Weiller PJ, Lena-Russo D, Disdier P. A new case of haemoglobin Chesapeake [5]. Haematologica. 2001;86(1):105. http:\/\/www.haematologica.it\/2001_01\/0105.htm."},{"key":"1429_CR36","doi-asserted-by":"publisher","unstructured":"C\u00fcr\u00fck MA. Hb H (beta4) disease in Cukurova, Southern Turkey. Haemoglobin. 2007;31(2):265\u201371. https:\/\/doi.org\/10.1080\/03630260701297279.","DOI":"10.1080\/03630260701297279"},{"key":"1429_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/03630269.2014.969373","volume":"38","author":"T Aksu","year":"2014","unstructured":"Aksu T, Yarali N, Bayram C, Fettah A, Avci Z, Tunc B. Homozygosity for HBA1: c.179G > A: Hb Adana in an infant. Hemoglobin. 2014;38:449\u201350.","journal-title":"Hemoglobin"},{"issue":"9","key":"1429_CR38","doi-asserted-by":"publisher","first-page":"e27220","DOI":"10.1002\/pbc.27220","volume":"65","author":"SA Singh","year":"2018","unstructured":"Singh SA, Sarangi S, Appiah-Kubi A, Hsu P, Smith WB, Gallagher PG, Chui DHK. Hb Adana (HBA2 or HBA1: c.179G &gt; A) and alpha thalassemia: Genotype-phenotype correlation. Pediatr Blood Cancer. 2018;65(9):e27220. https:\/\/doi.org\/10.1002\/pbc.27220.","journal-title":"Pediatr Blood Cancer"},{"key":"1429_CR39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12288-014-0406-0","volume":"31","author":"ST Bozdogan","year":"2015","unstructured":"Bozdogan ST, Yuregir OO, Buyukkurt N, Aslan H, Ozdemir ZC, Gambin T. Alpha-thalassemia mutations in Adana province, southern Turkey: genotype-phenotype correlation. Indian J Hematol Blood Transfus. 2015;31:223\u20138.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"1429_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/03630269.2013.775149","volume":"37","author":"IM Nainggolan","year":"2013","unstructured":"Nainggolan IM, Harahap A, Ambarwati DD, et al. Interaction of Hb Adana (HBA2: c.179G>A) with deletional and nondeletional (+)- thalassemia mutations: diverse haematological and clinical features. Haemoglobin. 2013;37:297\u2013305.","journal-title":"Haemoglobin."},{"key":"1429_CR41","doi-asserted-by":"crossref","first-page":"26994","DOI":"10.1038\/srep26994","volume":"6","author":"JA Tan","year":"2016","unstructured":"Tan JA, Kho SL, Ngim CF, Chua KH, Goh AS, Yeoh SL, George E. DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179 > A) with deletional or nondeletional alpha-thalassaemia. Sci Rep. 2016;6:26994.","journal-title":"Sci Rep"},{"key":"1429_CR42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/03630269.2015.1070732","volume":"39","author":"R Alibakhshi","year":"2015","unstructured":"Alibakhshi R, Mehrabi M, Omidniakan L, Shafieenia S. The spectrum of \ud6fc-thalassemia mutations in Kermanshah Province, West Iran. Haemoglobin. 2015;39:403\u20136.","journal-title":"Haemoglobin"},{"key":"1429_CR43","first-page":"564","volume":"15","author":"MT Akbari","year":"2012","unstructured":"Akbari MT, Hamid M. Identification of \ud6fc-globin chain variants: a report from Iran. Arch Iran Med. 2012;15:564\u20137.","journal-title":"Arch Iran Med"},{"key":"1429_CR44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM200008243430804","volume":"343","author":"FE Chen","year":"2000","unstructured":"Chen FE, Ooi C, Ha SY, Cheung BM, Todd D, Liang R, Chan TK, Chan V. Genetic and clinical features of haemoglobin H disease in Chinese patients. N Engl J Med. 2000;343:544\u201350.","journal-title":"N Engl J Med"},{"key":"1429_CR45","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.3390\/ijms15058835","volume":"15","author":"NF Yatim","year":"2014","unstructured":"Yatim NF, Rahim MA, Menon K, et al. Molecular characterization of \ud6fc- and \ud6fd-thalassaemia among Malay patients. Int J Mol Sci. 2014;15:8835\u201345.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1429_CR46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00277-009-0710-1","volume":"88","author":"V Arya","year":"2009","unstructured":"Arya V, Kumar R, Yadav RS, Dabadghao P, Agarwal S. Rare haemoglobin variant Hb I Philadelphia in north Indian family. Ann Hematol. 2009;88(9):927\u20139.","journal-title":"Ann Hematol"},{"key":"1429_CR47","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V10.10.999.999","volume":"10","author":"DL Rucknagel","year":"1955","unstructured":"Rucknagel DL, Page EB, Jasen WN. Haemoglobin I: an inherited haemoglobin anomaly. Blood. 1955;10:999\u20131009.","journal-title":"Blood."},{"key":"1429_CR48","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ejhg.2014.131","volume":"23","author":"J Traeger-Synodinos","year":"2015","unstructured":"Traeger-Synodinos J, Harteveld CL, Old JMM, Petrou M, Galanello R, Giordano P, et al. EMQN best practice guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur J Hum Genet. 2015;23:426\u201337.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1429_CR49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/bmm.13.103","volume":"8","author":"J Traeger-Synodinos","year":"2014","unstructured":"Traeger-Synodinos J, Harteveld CL. Advances in technologies for screening and diagnosis of hemoglobinopathies. Biomark Med. 2014;8(1):119\u201331.","journal-title":"Biomark Med"},{"key":"1429_CR50","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.3324\/haematol.2013.097220","volume":"99","author":"KM Musallam","year":"2014","unstructured":"Musallam KM, Cappellini MD, Daar S, et al. Serum ferritin level and morbidity risk in transfusion-independent patients with \u03b2-thalassemia intermedia: the ORIENT study. Haematologica. 2014;99:e218\u201321.","journal-title":"Haematologica."},{"key":"1429_CR51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.24231","volume":"91","author":"D Rund","year":"2016","unstructured":"Rund D. Thalassemia 2016: modern medicine battles an ancient disease. Am J Hematol. 2016;91:15\u201321.","journal-title":"Am J Hematol"},{"key":"1429_CR52","volume-title":"Guidelines for the management of transfusion-dependent thalassaemia (TDT)","author":"MD Cappellini","year":"2014","unstructured":"Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the management of transfusion-dependent thalassaemia (TDT). 3rd ed. Nicosia: Thalassaemia International Federation; 2014.","edition":"3"},{"key":"1429_CR53","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/j.1537-2995.2007.01416.x","volume":"47","author":"TE Delea","year":"2007","unstructured":"Delea TE, Edelsberg J, Sofrygin O, et al. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion. 2007;47:1919\u201329.","journal-title":"Transfusion."},{"issue":"7472","key":"1429_CR54","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature12751","volume":"502","author":"K Helin","year":"2013","unstructured":"Helin K, Dhanak D. Chromatin proteins and modifications as drug targets. Nature. 2013;502(7472):480\u20138.","journal-title":"Nature"},{"issue":"21","key":"1429_CR55","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/hmg\/ddm218","volume":"16","author":"SY Xie","year":"2007","unstructured":"Xie SY, Ren ZR, Zhang JZ, Guo X, Bin WQX, Wang S, et al. Restoration of the balanced \u03b1\/\u03b2-globin gene expression in \u03b2654-thalassemia mice using combined RNAi and antisense RNA approach. Hum Mol Genet. 2007;16(21):2616\u201325.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1429_CR56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.stem.2013.10.001","volume":"14","author":"H Xie","year":"2014","unstructured":"Xie H, Xu J, Hsu JH, et al. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. Cell Stem Cell. 2014;14(1):68\u201380.","journal-title":"Cell Stem Cell"},{"key":"1429_CR57","volume-title":"Agios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results at ASH","author":"Agios Pharmaceuticals, Inc. (NASDAQ: AGIO)","year":"2019","unstructured":"Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) Agios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results at ASH 2019."},{"key":"1429_CR58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia. Nature. 2010;467:318\u201322.","journal-title":"Nature"},{"key":"1429_CR59","doi-asserted-by":"crossref","unstructured":"Negre O, Eggimann AV, Beuzard JA, Ribeil P, Bourget S. Borwornpinyo, et al. gene therapy of the beta-hemoglobinopathies by Lentiviral transfer of the beta (a(T87Q))-globin gene, hum. Gene Ther. 2016;27:148\u201365. (http:\/\/www.ithanet.eu\/db\/ithagenes; http:\/\/globin.bx.psu.edu\/hbvar\/menu.html).","DOI":"10.1089\/hum.2016.007"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01429-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01429-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01429-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:18:32Z","timestamp":1624925912000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01429-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01429-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"17 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable; is a review paper that utilised information from previous journals, books, case studies etc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No illegal individual data are utilised in this review paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}